Clinical Trial Update: Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne [Phase 1, Phase 2]

View source ↗

Summary

Sanofi Pasteur is conducting a Phase 1/2 trial to evaluate the safety, efficacy and immunogenicity of an acne-targeted mRNA vaccine in participants with mild ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne

Drugs mentioned

• Acne mRNA vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Acne | Phase 1, Phase 2 | Status: RECRUITING